Skip to main content
Log in

Cortisol binding in human breast cancer: Correlation with antitumor immunity

  • Short Communications
  • Published:
Cancer Immunology, Immunotherapy Aims and scope Submit manuscript

Summary

The intensity of cortisol binding was measured in the cytosol fraction of the primary tumor obtained from 50 patients with stage I and II breast cancer. The state of cellular antitumor immunity of the same patients was investigated by the tube leucocyte adherence inhibition (LAI) test, performed with peripheral blood leucocytes 1–2 days preoperatively. It was found that the intensity of tumor cortisol binding correlates negatively with LAI values. Patients with high cortisol binding in their tumors have low LAI values, while low tumor cortisol binding is associated with higher antitumor immunity. The results suggest that high cortisol binding in the tumor might inhibit the tumor recognition process and/or the cellular immune defense mechanism and thus facilitate cancer development.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Amaral, L., Werthamer, S.: Identification of breast cancer transcortin and its inhibitory role in cell-mediated immunity. Nature 262, 589 (1976)

    Google Scholar 

  • Desousa, M., Fauchet, J.: The cellular basis of the mechanism of action of cortisone acetate on contact sensitivity to oxazolone in the mouse. Clin. Exp. Immunol. 10, 673 (1972)

    Google Scholar 

  • Dimitriu, A.: Suppression of macrophage arming by corticosteroids. Cell. Immunol. 21, 79 (1976)

    Google Scholar 

  • Fauci, A. S., Dale, D. C., Balow, J. E.: Glucocorticosteroid therapy: mechanism of action and clinical considerations. Ann. Intern. Med. 84, 304 (1976)

    Google Scholar 

  • Fazekas, A. G., MacFarlane, J. K.: Steroid hormone receptors in human breast cancer. The Endocrine Society, 57th Annual Meeting, New York, N.Y. Abstr. No. 356 (1975)

  • Fazekas, A. G., MacFarlane, J. K.: Macromolecular binding of glucocorticoids in human mammary carcinoma. Cancer Res. 37, 640 (1977a)

    Google Scholar 

  • Fazekas, A. G., MacFarlane, J. K.: Glucocorticoid receptors in human breast cancer tissue, In: Breast cancer, Proceedings of the International Breast Cancer Conference, Lucerne, Switzerland. Montagne, A. C. W. et al., (eds.), p. 149. New York: Alan R. Liss 1977b

    Google Scholar 

  • Fazekas, A. G., MacFarlane, J. K.: Glucocorticoid receptors in human breast carcinoma. Annals of the Royal College of Physicians and Surgeons of Canada 10, 68, (Abstract) (1977c)

    Google Scholar 

  • Fazekas, A. G., MacFarlane, J. K.: Cortisol in human breast cancer tissue. J. Clin. Endocrinol. Metab. 44, 1218 (1977d)

    Google Scholar 

  • Fazekas, A. G., Thomson, D. M. P., MacFarlane, J. K., Weinberg, M.: In: Preparation (1978)

  • Flores, M., MacFarlane, J. K., Thomson, D. M. P.: The effect of surgery on antitumour immunity as measured by the tube leucocyte adherence inhibition assay in breast cancer. Surg. Forum 27, 91 (1976)

    Google Scholar 

  • Grosser, N., Thomson, D. M. P.: Cell-mediated antitumour immunity in breast cancer patients evaluated by antigen-induced leucocyte adherence inhibition in test tubes. Cancer Res. 35, 2571 (1975)

    Google Scholar 

  • Grosser, N., Thomson, D. M. P.: The leucocyte (monocyte) adherence inhibition assay for the detection of anti-tumour immunity. III. “Blockade” of monocyte reactivity by excess free antigen and immune complexes in advanced cancer patients. Int. J. Cancer 18, 58 (1976)

    Google Scholar 

  • Grosser, N., Marti, J. H., Proctor, J. W., Thomson, D. M. P.: Tube leucocyte adherence inhibition assay for the detection of anti-tumour immunity. I. Monocyte is the reactive cell. Int. J. Cancer 18, 29 (1976)

    Google Scholar 

  • Halliday, W. J., Miller, S.: Leucocyte adherence inhibition: simple test for cell-mediatied tumour immunity and serum blocking factors. Int. J. Cancer 9, 477 (1972)

    Google Scholar 

  • Lowry, O. H., Rosebrough, N. J., Farr, A. L., Randall, R. J.: Protein measurement with the folin phenol reagent. J. Biol. Chem. 193, 265 (1951)

    CAS  PubMed  Google Scholar 

  • McGuire, W. L., DeLaGarza, M.: Improved sensitivity in the measurement of estrogen receptor in human breast cancer. J. Clin. Endocrinol. Metab. 37, 896 (1973)

    Google Scholar 

  • Neville, A. M., Symington, T.: Systemic factors produced by human neoplasms. In: Biology of cancer. Ambrose, E. J., Roe, F. J. C. (eds.), p. 126. Chichester: Ellis Horwood Ltd. 1975

    Google Scholar 

  • Riley, V.: Mouse mammary tumors: alteration of incidence as apparent function of stress. Science 189 465 (1975)

    Google Scholar 

  • Weston, W. L., Mandel, M. J., Yeckley, J. A.: Mechanism of cortisol inhibition of adoptive transfer of tuberculin sensitivity. J. Lab. Clin. Med. 82, 366 (1973)

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Fazekas, A.G., Marti, J., Flores, M. et al. Cortisol binding in human breast cancer: Correlation with antitumor immunity. Cancer Immunol Immunother 5, 145–147 (1978). https://doi.org/10.1007/BF00199989

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00199989

Keywords

Navigation